| Enterovirus (4) |  |
| Hepatitis (21) | |
| Herpes virus (12) | |
| Lentivirus (7) | |
| Papillomavirus (3) | |
| Viruses (427) | |
| Enterovirus (4) | |
| Hepatitis (21) | |
| Herpes virus (12) | |
| Lentivirus (7) | |
| Papillomavirus (3) | |
| Viruses (427) | |
and get around the need to screen for diseases such as HIV and hepatitis. Currently in the UK around 1. 6 million pints of blood are needed every year
There is also an increasing public health concern with plasma derived HSA with its potential risk for transmission of blood-derived infectious pathogens such as hepatitis and HIV.
Business watch A generation of drugs with the potential to cure hepatitis C is set to flood the market.
and drug behemoth Merck, headquartered in Whitehouse Station, New jersey, both released promising results from late-stage clinical trials of their leading drugs against the hepatitis C virus (HCV).
Business Hepatitis approvals As expected, the US Food and Drug Administration has approved what is only the second drug to directly target the hepatitis C virus. Telaprevir (Incivek),
Hepatitis C hopefuls Pharmaceutical giant Bristol-myers squibb of New york city has become the latest company to spend billions on the promise of hepatitis C treatments.
Georgia. Inhibitex's main asset is a compound against hepatitis C that is in phase II trials.
New jersey, which has three treatments for hepatitis C in clinical trials. See go. nature. com/qjoqfn for more on hepatitis C drugs.
Teva rethink Israeli pharmaceutical firm Teva, the world's largest maker of generic drugs, may shift its focus towards branded medicines after it announced a new chief executive.
and to push forward candidate drugs that include several hepatitis  C antivirals. Stem-cell transfer  Pioneering biotechnology company Geron is shedding its assets in human embryonic stem cells.
Hepatitis drug A new hepatitis-C drug sofosbuvir, has been found to be highly effective in clinical trials.
the drug is one of several in development that could replace existing hepatitis-C treatments,
Maryland, had published falsified data on the immune responses of patients with hepatitis to a newly discovered virus. A week earlier, Dong-Pyou Han,
A study published in October showed the mice predicted how well a drug for treating hepatitis C would be metabolized by humans.
and hepatitis where liver tissue has been replaced largely by scar tissue. Multiple studies have shown that coffee can lower the risk of cirrhosis by as much as 80%the strongest effect for those who drank 4 or more cups per day (23 24 25.
For the first time researchers at the University of North carolina have discovered that Hepatitis a virus a common cause of enterically-transmitted hepatitis takes on characteristics of both virus types depending on
The first kidney transplant in Utah using an organ from a donor with hepatitis C. The first en bloc kidney where two pediatric kidneys were transplanted into one adult.
Modern herbal treatments with Astragalus membranaceus root (often in concert with other herbs) are partly based on clinical trials showing benefits in strengthening immune function during viral (e g. chronic hepatitis)
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011